David Jeffrey Katz Sells 12,300 Shares of RadNet, Inc. (NASDAQ:RDNT) Stock

RadNet, Inc. (NASDAQ:RDNT) EVP David Jeffrey Katz sold 12,300 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $81.65, for a total value of $1,004,295.00. Following the completion of the transaction, the executive vice president now directly owns 62,909 shares in the company, valued at approximately $5,136,519.85. This represents a 16.35 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

RadNet Stock Up 1.3 %

NASDAQ RDNT opened at $82.49 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16. The stock has a market capitalization of $6.11 billion, a PE ratio of -1,178.26 and a beta of 1.75. RadNet, Inc. has a 1 year low of $32.15 and a 1 year high of $93.65. The business’s 50-day moving average is $72.18 and its 200 day moving average is $64.84.

Wall Street Analyst Weigh In

A number of research analysts recently commented on RDNT shares. Barclays raised RadNet from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $57.00 to $79.00 in a research note on Friday, September 6th. Sidoti raised RadNet to a “strong-buy” rating in a research note on Friday, October 4th. Truist Financial raised their price objective on RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. Finally, Jefferies Financial Group raised their price objective on RadNet from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, September 19th. One investment analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, RadNet presently has a consensus rating of “Moderate Buy” and a consensus target price of $74.75.

Institutional Trading of RadNet

Institutional investors and hedge funds have recently bought and sold shares of the stock. Covestor Ltd lifted its holdings in shares of RadNet by 10,875.0% during the third quarter. Covestor Ltd now owns 439 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 435 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of RadNet by 774.2% during the second quarter. Nisa Investment Advisors LLC now owns 848 shares of the medical research company’s stock valued at $50,000 after purchasing an additional 751 shares during the last quarter. GAMMA Investing LLC lifted its holdings in shares of RadNet by 74.7% during the second quarter. GAMMA Investing LLC now owns 865 shares of the medical research company’s stock valued at $51,000 after purchasing an additional 370 shares during the last quarter. Highline Wealth Partners LLC bought a new stake in shares of RadNet during the third quarter valued at approximately $68,000. Finally, Peterson Financial Group Inc. bought a new stake in shares of RadNet during the third quarter valued at approximately $90,000. 77.90% of the stock is currently owned by hedge funds and other institutional investors.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.